CrossrefInfokaart
Influence of dosage and therapeutic interval on the incidence of severe side effects of immunotherapy with PD-1 inhibitors in malignant melanoma
EJC Skin Cancer · 2026 · 4 · 101170
DOI: 10.1016/j.ejcskn.2026.101170 ↗Samenvatting
Geen abstract beschikbaar.
EUVIMED